基本信息
views: 67
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Laura Sepp-Lorenzino, Ph.D. oversees Research and Early Development at Intellia Therapeutics in her role as Chief Scientific Officer. Intellia’s leading CRISPR/Cas9-based platform supports a full-spectrum strategy, which deploys differentiated, modular solutions across in vivo and ex vivo therapeutic applications. Before joining Intellia, Laura was VP, Head of Nucleic Acid Therapies and member of the External Innovation team at Vertex Pharmaceuticals, with previous positions as VP and entrepreneur-in-residence at Alnylam Pharmaceuticals, Inc., and Executive Director RNA Therapeutics at Merck & Co., Inc. In addition to her extensive experience in nucleic acid therapies, Laura has expertise in oncology drug discovery and development acquired earlier in her career by leading the Cancer Research Department at Merck West Point and working as an assistant attending molecular biologist at Memorial Sloan-Kettering Cancer Center. She received her professional degree in Biochemistry from the University of Buenos Aires, Argentina and both her M.S. and Ph.D. in Biochemistry from New York University. Laura is a member of the board of directors of Taysha Gene Therapies, the Alliance for Regenerative Medicine and the Oligonucleotide Therapeutics Society, and sits on the scientific advisory board of Thermo Fisher Scientific, Zymergen Inc., and the U.K. Nucleic Acid Therapy Accelerator, and is a member of the Editorial Board of Nucleic Acid Therapeutics (NAT).
Research Interests
Papers共 105 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Hilary J Longhurst, Karen Lindsay,Remy S Petersen,Lauré M Fijen, Padmalal Gurugama, David Maag,James S Butler, Mrinal Y Shah, Adele Golden,Yuanxin Xu,Carri Boiselle, Joseph D Vogel,
The New England journal of medicineno. 5 (2024): 432-441
S. Engelbeen,Svetlana Pasteuning-Vuhman, Joke Boertje-van der Meulen,Rubina Parmar,Klaus Charissé,Laura Sepp‐Lorenzino,Muthiah Manoharan,Annemieke Aartsma‐Rus,M. van Putten
Nucleic Acid Therapeuticsno. 1 (2023): 26-34
Nucleic acid therapeuticsno. 4 (2023): 233-233
Sarah Engelbeen,Svetlana Pasteuning-Vuhman, Joke Boertje-van der Meulen,Rubina Parmar,Klaus Charisse,Laura Sepp-Lorenzino,Muthiah Manoharan,Annemieke Aartsma-Rus,Maaike van Putten
JOURNAL OF HEPATOLOGYno. 4 (2023): 924-932
Cited0Views0Bibtex
0
0
Donna Klein,Shalom Goldberg,Christopher S Theile,Richard Dambra,Kathleen Haskell, Elise Kuhar,Tricia Lin,Rubina Parmar,Muthiah Manoharan, Mark Richter, Meizhen Wu, Jeannine Mendrola Zarazowski,
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn